GreMERSfi

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGreMERSfi

Drug Alias NameGREVAX/MERSMERS-CoV vaccine (Greffex)recombinant adenovirus vector vaccine (Greffex)Middle East respiratory syndrome vaccine (Greffex)SARS-CoV-2 recombinant adenovirus vector vaccine (Greffex)

ClassificationVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGreffex Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGreffex Inc

Active IndicationsN/A

Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A